Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Masakazu Ekawa"'
Autor:
Hiroshi Kusunoki, Kazumi Ekawa, Masakazu Ekawa, Nozomi Kato, Keita Yamasaki, Masaharu Motone, Hideo Shimizu
Publikováno v:
Medicines, Vol 10, Iss 4, p 27 (2023)
Background: The rise in antibody titers against the novel coronavirus (SARS-CoV-2) and its duration are considered an important indicator for confirming the effect of a COVID-19 vaccine, and self-paid tests of antibody titer are conducted in many fac
Externí odkaz:
https://doaj.org/article/50d2f84939be44258b481deec2f7dd5b
Autor:
Hiroshi Kusunoki, Kazumi Ekawa, Masakazu Ekawa, Nozomi Kato, Keita Yamasaki, Masaharu Motone, Hideo Shimizu
BackgroundThe rise in antibody titers against the novel coronavirus (SARS-CoV-2), and its duration is considered an important indicator for confirming the efficacy of the COVID-19 vaccine, and self-paid tests of antibody titer are conducted at many f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf939e0bf0ecbc97e8405705c0e41aa9
https://doi.org/10.1101/2023.03.03.23286284
https://doi.org/10.1101/2023.03.03.23286284
Autor:
Masato Kuchii, Akiko Nakatani, Munekazu Tajiri, Yoshio Amano, Toshio Nishi, Isao Yataka, Shingo Nishioka, Chie Nakai, Masakazu Ekawa
Publikováno v:
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 65(6)
Case 1 was a 55 year old female whose primary complaint was pyrexia. Anamnesis consisted of a fever at a 39 degrees C level beginning on September 15, 1987 with headache and muscle pain. The patient was examined by a nearby physician. Despite taking
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4be82f015041099ea719db510c54294
https://pubmed.ncbi.nlm.nih.gov/1919107
https://pubmed.ncbi.nlm.nih.gov/1919107